Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.150
-0.050 (-4.17%)
At close: Oct 14, 2026, 4:00 PM EDT
1.180
+0.030 (2.61%)
After-hours: Oct 14, 2026, 7:57 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $6.06 million as of October 14, 2026. It is the 43,991st most valuable company in the world and the 5,907th biggest in the United States. Its market cap has decreased by 44.54% in one year.
Market Cap
6.06M
Enterprise Value
-4.60M
1-Year Change
-44.54%
Global Rank
Country Rank
#5,907 United States
Category
ChartMarket Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $6.06M, a decrease of -89.41%. That is a compound annual growth rate of -34.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 6.06M | 3.65% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 6.85M |
| Skye Bioscience | 6.77M |
| FibroBiologics | 6.68M |
| Alzamend Neuro | 6.51M |
| Evogene | 6.50M |
| NeuroSense Therapeutics | 6.45M |
| Traws Pharma | 6.30M |
| Enveric Biosciences | 6.27M |